Stocks and Investing Stocks and Investing
Mon, September 13, 2021
Fri, September 10, 2021

Elemer Piros Maintained (APLS) at Strong Buy with Decreased Target to $46 on, Sep 10th, 2021


Published on 2024-10-27 17:53:25 - WOPRAI, Elemer Piros
  Print publication without navigation


Elemer Piros of Roth Capital, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Decreased Target from $80 to $46 on, Sep 10th, 2021.

Elemer has made no other calls on APLS in the last 4 months.



There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 0 agree with Elemer's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Elemer


  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $74 on, Thursday, August 19th, 2021
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $102 on, Tuesday, August 10th, 2021
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $101 on, Friday, July 2nd, 2021
  • Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $82 on, Friday, May 21st, 2021

Contributing Sources